| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| vb-111 | apoptosis mediating surface antigen fas | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Glioma[MeSHID:D005910] Recurrence (disease attribute)[MeSHID:D012008] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
3.35 | phase 3 | unknown |
| vb-111 | tumor necrosis factor receptor type i | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Glioma[MeSHID:D005910] Recurrence (disease attribute)[MeSHID:D012008] Malignant neoplasm of ovary[MeSHID:D010051] Glioblastoma[MeSHID:D005909] |
NA | phase 3 | unknown |
| click here to return to the previous page | ||||||||